| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A CASE OF B-CELL LYMPHOBLASTIC LYMPHOMA WITH PRIMARY BONE INVOLVEMENT: A MIMICKER OF RHEUMATOLOGICAL AND INFECTIOUS DISEASE
|
Morales, S.
|
|
|
121 |
S |
p. S73
|
artikel
|
| 2 |
ADOLESCENT AGE AT DIAGNOSIS MAY NEGATIVELY IMPACT CLINICAL OUTCOMES IN PEDIATRIC POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
|
Reddy, S.
|
|
|
121 |
S |
p. S57-S58
|
artikel
|
| 3 |
ALK+ ALCL EVADES IMMUNE SURVEILLANCE THROUGH NPM-ALK-DRIVEN EPIGENETIC REPRESSION OF Cd48
|
Wu, R.
|
|
|
121 |
S |
p. S3
|
artikel
|
| 4 |
ALK INHIBITOR PLUS VINBLASTINE FOR REFRACTORY/RELAPSED PEDIATRIC ALK+ ANAPLASTIC LARGE CELL LYMPHOMA: A PROSPECTIVE, ONE-ARM, OPEN-LABEL REAL-WORLD STUDY
|
Wang, S.
|
|
|
121 |
S |
p. S66-S67
|
artikel
|
| 5 |
ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT
|
d’Hautefeuille, C.
|
|
|
121 |
S |
p. S68-S69
|
artikel
|
| 6 |
ALK INIHIBITOR THERAPY IN ALCL
|
Sekimizu, M.
|
|
|
121 |
S |
p. S63
|
artikel
|
| 7 |
A MULTICENTER PILOT STUDY USING INDUCTION CHEMO-IMMUNOTHERAPY FOLLOWED BY CONSOLIDATION WITH REDUCED TOXICITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANT IN ADVANCED STAGE MATURE NON-APLASTIC T/NK-CELL LYMPHOMA/ LEUKEMIA IN CHILDREN, ADOLESCENT, AND YOUNG ADULTS (CAYA)
|
Xavier, A.
|
|
|
121 |
S |
p. S26
|
artikel
|
| 8 |
ANAPLASTIC LYMPHOMA KINASE INHIBITION ACTIVATES AUTOPHAGY IN ALK+ ANAPLASTIC LARGE CELL LYMPHOMA
|
Hoogstra, D.
|
|
|
121 |
S |
p. S67-S68
|
artikel
|
| 9 |
A NOVEL CYTOKINE-ANTIBODY FUSION PROTEIN, N-820, TO ENHANCE THE FUNCTIONS OF EX-VIVO EXPANDED NATURAL KILLER CELLS AGAINST BURKITT LYMPHOMA
|
Chu, Y.
|
|
|
121 |
S |
p. S17-S18
|
artikel
|
| 10 |
A NOVEL PATHOGENIC SH2D1A MUTATION CAUSES X-LINKED LYMPHOPROLIFERATIVE DISEASE MANIFESTED BY NON-HODGKIN LYMPHOMA AND DYSGAMMAGLOBULINEMIA
|
Gilad, G.
|
|
|
121 |
S |
p. S44-S45
|
artikel
|
| 11 |
AN UNUSUAL PRESENTATION OF A RARE PEDIATRIC DISEASE
|
Patel, G.
|
|
|
121 |
S |
p. S52
|
artikel
|
| 12 |
A PEDIATRIC BURKITT LYMPHOMA PATIENT-DERIVED XENOGRAFT RESOURCE OF PRIMARY AND RELAPSE/REFRACTORY DISEASE
|
Steel, C.
|
|
|
121 |
S |
p. S48-S49
|
artikel
|
| 13 |
A PHASE I TRIAL OF TARGETED IMMUNOTHERAPY WITH DARATUMUMAB FOLLOWING MYELOABLATIVE TOTAL BODY IRRADIATION (TBI)-BASED CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATON IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH HIGH-RISK T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC FACILITATED STUDY
|
Quigg, T.
|
|
|
121 |
S |
p. S71-S73
|
artikel
|
| 14 |
A RARE CASE OF PRIMARY CUTANEOUS PRECURSOR T-CELL LYMPHOBLASTIC LYMPHOMA IN A BRAZILIAN CHILD
|
Barlera, T.
|
|
|
121 |
S |
p. S71
|
artikel
|
| 15 |
A RARE CASE OF PRIMARY OCULAR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN A BRAZILIAN CHILD
|
Barlera, T.
|
|
|
121 |
S |
p. S54
|
artikel
|
| 16 |
A TARGETED GENE EXPRESSION CLASSIFIER IDENTIFIES PEDIATRIC T-ALL PATIENTS AT HIGH RISK FOR END INDUCTION MINIMAL RESIDUAL DISEASE POSITIVITY
|
Meyer, L.
|
|
|
121 |
S |
p. S34-S35
|
artikel
|
| 17 |
A UK POPULATION-BASED STUDY OF NON-HODGKIN LYMPHOMA IN ADOLESCENTS AND YOUNG ADULTS: TREATMENT-RELATED OUTCOMES FOR DIFFUSE LAREG B-CELL
|
Carr, R.
|
|
|
121 |
S |
p. S59
|
artikel
|
| 18 |
B-CELL NHL RELAPSES IN PPLLSG PATIENTS IN YEARS 2004–2021
|
Latos-Grażyńska, E.
|
|
|
121 |
S |
p. S20-S21
|
artikel
|
| 19 |
BCR EXPRESSION IN BURKITT LYMPHOMA: NEW INSIGHT IN MUTATIONAL LANDSCAPE
|
Siciliano, M.
|
|
|
121 |
S |
p. S1-S2
|
artikel
|
| 20 |
BLOCKING THE BCL10-MALT1 INTERACTION IN DIFFUSE LARGE B-CELL LYMPHOMA
|
Maurer, L.
|
|
|
121 |
S |
p. S23
|
artikel
|
| 21 |
BONE MARROW INFILTRATION AS A PROGNOSTICE FACTOR IN PEDIATARIC BURKITT LYMPHOMA PATIENTS
|
Rahman, H.
|
|
|
121 |
S |
p. S38
|
artikel
|
| 22 |
BRENTUXIMAB-BENDAMUSTINE IN CHILDREN, ADOLESCENT AND YOUNG ADULTS WITH RELAPSED/REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA
|
Vinti, L.
|
|
|
121 |
S |
p. S65
|
artikel
|
| 23 |
BRENTUXIMAB VEDOTIN PLUS VIGEPP CHEMOTHERAPY FOR RELAPSED/REFRACTORY ADOLESCENT HODGKIN LYMPHOMA
|
Tsaplina, N.
|
|
|
121 |
S |
p. S60
|
artikel
|
| 24 |
BRIGATINIB SHOWS PRECLINICAL PROMISE FOR AGGRESSIVE RELAPSED/REFRACTORY AK = LK-POSITIVE ALCL
|
Matthews, J.
|
|
|
121 |
S |
p. S16-S17
|
artikel
|
| 25 |
“BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION”: NEITHER BURKITT-LYMPHOMA NOR DIFFUSE LARGE B-CELL LYMPHOMA. WHAT THE MICROENVIRONMENT TELLS US
|
Del Corvo, M.
|
|
|
121 |
S |
p. S46
|
artikel
|
| 26 |
BURKITT LYMPHOMA AND HIGH-GRADE B-CELL LYMPHPHOMA WITH 11q ABBERRATIONS SHARE A TRANSCRIPTIONAL PROFILE RESEMBLING A SUBPOPULATION OF EARLY DARK ZONE CELLS
|
Di Stefano, G.
|
|
|
121 |
S |
p. S3-S4
|
artikel
|
| 27 |
CD72 NANOBODY CAR-T CELLS HAVE POTENT ANTITUMOR EFFICACY IN B CELL MALIGNANCIES
|
Temple, W.
|
|
|
121 |
S |
p. S8
|
artikel
|
| 28 |
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PEDIATRIC ANAPLASTIC LARGE T-CELL LYMPHOMA
|
Rocco, A.
|
|
|
121 |
S |
p. S54-S55
|
artikel
|
| 29 |
CHARACTERISTICS AND OUTCOME OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER SOLID ORGAN TRANSPLANTATION
|
Vergote, V.
|
|
|
121 |
S |
p. S26
|
artikel
|
| 30 |
CHARACTERIZATION OF IG-MYC-BREAKPOINTS AND THEIR APPLICATION FOR QUANTITATIVE MINIMAL DISEASE MONITORING IN HIGH-RISK PEDIATRIC BURKITT-LYMPHOMA AND –LEUKEMIA
|
Damm-Welk, C.
|
|
|
121 |
S |
p. S22
|
artikel
|
| 31 |
CHARACTERIZING THROMBOSIS IN CHILDREN & ADOLESCENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
|
Karsenty, C.
|
|
|
121 |
S |
p. S58
|
artikel
|
| 32 |
CHILDHOOD AND ADOLESCENT HODGKIN REED-STERNBERG CELLS DEMONSTRATE UNIQUE GENE EXPRESSION SIGNATURE CONSISTENT WITH ONCOGENIC-INDUCED SENESCENCE
|
Agrusa, J.
|
|
|
121 |
S |
p. S10
|
artikel
|
| 33 |
CLINICAL FEATURES AND TREATMENT OUTCOME OF CHILDREN WITH LYMPHOBLASTIC LYMPHOMA IN TAIWAN
|
Chen, S.
|
|
|
121 |
S |
p. S70
|
artikel
|
| 34 |
CLINICAL SPECTRUM OF PRECURSOR B-CELL LYMPHOBLASTIC MALIGNANCIES: A LARGE COHORT STUDY OF 364 PEDIATRIC PATIENTS
|
Kroeze, E.
|
|
|
121 |
S |
p. S21
|
artikel
|
| 35 |
CLINICOPATHOLOGIC FEATURES AND PROGNOSIS OF PEDIATRIC HIGH-GRADE B-CELL LYMPHOMA: A MULTICENTER ANALYSIS
|
Zhao, Y.
|
|
|
121 |
S |
p. S42-S43
|
artikel
|
| 36 |
COMBINATION TREATMENT WITH VINBLASTINE AND CRIZOTINIB IN PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA
|
Knörr, F.
|
|
|
121 |
S |
p. S66
|
artikel
|
| 37 |
COMBINED BORTEZOMIB AND VENETOCLAX TARGETS THE PRO-SURVIVAL FUNCTIONS OF LATENT VIRAL PROTEINS IN EPSTEIN-BARR VIRUS-DRIVEN LYMPHOPROLIFERATIVE DISEASES
|
Chiang, A.
|
|
|
121 |
S |
p. S25
|
artikel
|
| 38 |
COMBINED BRENTUXIMAB VEDOTIN AND NIVOLUMAB FOR TREATMENT OF RELAPSED/REFRACTORY PEDIATRIC HOGDKIN LYMPHOMA AND GREY ZONE LYMPHOMA
|
Lam, G.
|
|
|
121 |
S |
p. S56-S57
|
artikel
|
| 39 |
Contents
|
|
|
|
121 |
S |
p. iii
|
artikel
|
| 40 |
DEFINING THE SYSTEMIC IMMUNE LANDSCAPE IN CHILDREN AT AN INCREASED RISK OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE: THE IMMUNOLOGY OF THYMECTOMY AND CHILDHOOD CARIDAC TRANSPLANT (ITHACA) STUDY
|
Offor, U.
|
|
|
121 |
S |
p. S56
|
artikel
|
| 41 |
DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN PATIENTS WITH ALAPLASTIC NHL AND LONG QT SYNDROME
|
Maciejka-Kemblowska, L.
|
|
|
121 |
S |
p. S65-S66
|
artikel
|
| 42 |
EBV-DRIVEN LYMPHOID NEOPLASMS ASSOCIATED WITH ALL MAINTENANCE THERAPY: AN INTERNATIONAL OBSERVATINAL STUDY
|
Elitzur, S.
|
|
|
121 |
S |
p. S5
|
artikel
|
| 43 |
Editorial Board
|
|
|
|
121 |
S |
p. ii
|
artikel
|
| 44 |
EFFICACY AND SAFETY OF SEQUENTIAL DIFFERENT B CELL ANTIGEN-TARGETED CAR T-CELL THERAPY FOR PEDIATRIC REFRACTORY/ RELAPSED BURKITT LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT
|
Liu, Y.
|
|
|
121 |
S |
p. S32-S33
|
artikel
|
| 45 |
EPSTEIN-BARR VIRUS ORCHESTRATE THE TUMOR MICROENVIRONMENT OF BURKITT LYMPHOMA
|
Siciliano, M.
|
|
|
121 |
S |
p. S9
|
artikel
|
| 46 |
ESTABLISHING THE OPTIMAL WAY TO ADMINISTER ANAPLASTIC LYMPHOMA KINASE (ALK) TYROSINE KINASE INHIBITORS (TKIs) IN PAEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) TO PREVENT/ DELAY RESISTANCE GENERATION
|
Hare, L.
|
|
|
121 |
S |
p. S36-S37
|
artikel
|
| 47 |
EXCELLENT OUTCOME OF CHILDREN/ADOLESCENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA TREATED WITH LMB-BASED CHEMOTHERAPY WITH RITUXIMAB
|
Dourthe, M.
|
|
|
121 |
S |
p. S10-S11
|
artikel
|
| 48 |
FDG-PET/CT IMAGING IN PEDIATRIC PRECURSOR B-CELL LYMPHOBLASTIC LYMPHOMA (BCP-LBL) SHOWS BONE (MARROW) INVOLVEMENT IN A VAST MAJORITY OF PATIENTS
|
Kroeze, E.
|
|
|
121 |
S |
p. S73-S74
|
artikel
|
| 49 |
18F-FDG-PET/CT IN THE ASSESSMENT OF BONE MARROW INVOLVEMENT IN PEDIATRIC NON-HODGKIN LYMPHOMA- A SINGLE CENTER EXPEREIENCE
|
Siri, M.
|
|
|
121 |
S |
p. S19-S20
|
artikel
|
| 50 |
FLOW CYTOMETRY OF CEREBROSPINAL FLUID FOR DETECTION OF CENTRAL NERVOUS SYSTEM INVOLVEMENT IN CHILDHOOD NON-HODGKIN LYMPHPOMA
|
Thastrup, M.
|
|
|
121 |
S |
p. S49
|
artikel
|
| 51 |
FULMINANT, EBV DRIVEN PLASMACYTIC POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) WITH LOSS OF 1P AND GAIN OF TP53/CEP17 AND IGH BONE MARROW INVOLVEMENT AFTER LIVER TRANSPLANT IN 17-MONTH OLD BOY
|
Pavasovic, V.
|
|
|
121 |
S |
p. S53-S54
|
artikel
|
| 52 |
FUNCTIONAL CHARACTERIZATION OF POTENTIAL DIAGNOSTIC TARGETS IN BURKITT-NHL
|
te Vrugt, M.
|
|
|
121 |
S |
p. S47-S48
|
artikel
|
| 53 |
GEMCITABINE, OXALIPLATIN, AND ANTI-CD20 THERAPY IS SAFE AND EFFECTIVE IN CHILDREN AND YOUNG ADULTS WITH NON-HODGKIN LYMPHOMA UNFIT FOR INTENSIVE THERAPY
|
Bender, J.
|
|
|
121 |
S |
p. S63-S64
|
artikel
|
| 54 |
GENOME-WIDE GENOMIC ABNORMALITIES AND FUNCTIONAL ESSENTIAL GENES IN BURKITT LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Zhou, P.
|
|
|
121 |
S |
p. S21-S22
|
artikel
|
| 55 |
GRK2, AN INHIBITOR OF MALT1-DEPEDENT ONCOGENIC SIGNALING, IS DOWNREGULATED BY microRNA IN ABC-DLBCL
|
Cheng, J.
|
|
|
121 |
S |
p. S50
|
artikel
|
| 56 |
IDENTIFICATION OF GENETIC PREDISPOSITION TO CHILDHOOD LYMPHOMAS – PRELIMINARY DATA
|
Szmyd, B.
|
|
|
121 |
S |
p. S4
|
artikel
|
| 57 |
IL10RA IS A CANDIDATE DRIVER GENE IN BURKITT-LIKE LYMPHOMA WITH 11q ABERRATION
|
Blain, A.
|
|
|
121 |
S |
p. S50-S51
|
artikel
|
| 58 |
IMMUNOGLOBULIN SUBCLASSES OF ANTI-ALK ANTIBODIES IN PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA
|
Knörr, F.
|
|
|
121 |
S |
p. S28
|
artikel
|
| 59 |
IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL
|
Alexander, S.
|
|
|
121 |
S |
p. S8-S9
|
artikel
|
| 60 |
IMPROVING TREATMENT OUTCOMES FOR CHILDREN WITH ENDEMIC BURKITT LYMPHOMA (eBL) IN SUB-SAHARAN AFRICA (SSA)
|
Ferraresso, M.
|
|
|
121 |
S |
p. S39-S40
|
artikel
|
| 61 |
INHIBITION OF N6-METHYLADENOSINE (m6A) MODIFICATION AS A NOVEL TREATMENT STRATEGY FOR ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
|
Mun, L.
|
|
|
121 |
S |
p. S29
|
artikel
|
| 62 |
INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY
|
Minard-Colin, V.
|
|
|
121 |
S |
p. S43
|
artikel
|
| 63 |
INTERIM ANALYSIS OF CHINA-NET CHILDHOOD LYMPHOMA GROUP CNCL-NHL-2017 PROTOCOL IN THE TREATMENT OF CHILDREN WITH DIFFUSE LARGE B-CELL LYMPHOMA
|
Fu, Y.
|
|
|
121 |
S |
p. S41-S42
|
artikel
|
| 64 |
INTERMITTENT LORLATINIB DOSING IN RELAPSED/REFREACTORY ALCL PROVIDES RAPID AND DURABLE RESPONSES. FREQUENT MRD MEASUREMENT SUGGEST DRUG-DRIVEN DEPENDENCY DEPRIVATION MECHANISM
|
Sterba, J.
|
|
|
121 |
S |
p. S64-S65
|
artikel
|
| 65 |
IRF4 GENE REARRANGEMANT IN PEDIATRIC AND ADOLESCENT PATIENTS DIAGNOSED WITH LARGE B-CELL LYMPHOMA
|
Gooch, M.
|
|
|
121 |
S |
p. S43
|
artikel
|
| 66 |
IS A MODIFIED BFM REGIMEN WITH 1 Gram/m2 METHOTREXATE AS EFFECTIVE AS 5 Gram/m2 IN PEDIATRIC ADVANCED-STAGE NONLYMPHOBLASTIC NON-HODGKIN LYMPHOMA?
|
Kebudi, R.
|
|
|
121 |
S |
p. S41
|
artikel
|
| 67 |
LONG TERM PULMONARY AND CARDIAC FUNCTION AFFECTION AMONG NON-HODGKIN LYMPHOMA
|
Ayad, A.
|
|
|
121 |
S |
p. S13
|
artikel
|
| 68 |
MATURE B CELL NON-HODGKIN LYMPHOMA TREATMENT AND RESULTS IN A RETROSPECTIVE COHORT OF CHILDREN AND ADOLESCENTS TREATED BETWEEN 2016 AND 2020 IN LATIN AMERICA
|
Chantada, G.
|
|
|
121 |
S |
p. S19
|
artikel
|
| 69 |
MCL-1 INHIBITORS INDUCES APOPTOSIS IN VITRO IN BURKITT LYMPHOMA CELL LINES AND INHIBITS IN VIVO BURKITT LYMPHOMA PROGRESSION
|
Daly, T.
|
|
|
121 |
S |
p. S64
|
artikel
|
| 70 |
MiR-146a-5p IS ENRICHED IN PLASMA SMALL EXTRACELLULAR VESICLES OF PEDIATRIC ALCL PATIENTS WITH POOR PROGNOSIS AND HAS A ROLE IN MACROPHAGE POLARIZATION
|
Garbin, A.
|
|
|
121 |
S |
p. S47
|
artikel
|
| 71 |
MODELLING THE CLONAL EVOLUTION OF BURKITT LYMPHOMA USING PATIENT-DERIVED XENOGRAFTS
|
Chang, S.
|
|
|
121 |
S |
p. S51
|
artikel
|
| 72 |
MOLECULAR GENETICS ANALYSIS OF B-CELL PRECURSOR LYMPHOMA IN PEDIATRIC AND ADOLESCENT PATIENTS REVEALS HIGH FREQUENCY OF KMT2A TRANSLOCATIONS
|
Iaccarino, I.
|
|
|
121 |
S |
p. S37
|
artikel
|
| 73 |
MULTICENTER PILOT TRIAL OF INTRATHECAL LIPOSOMAL CYTARABINE IN CAYA WITH MATURE DE-NOVO B-NHL
|
Goldman, S.
|
|
|
121 |
S |
p. S34
|
artikel
|
| 74 |
MULTI-INSTITUTIONAL EXPERIENCE OF FENTANYL FOR BROWN FAT MITIGATION IN 18FDG-PET/CT FOR PEDIATRIC ONCOLOGY PATIENTS
|
Gaylord, W.
|
|
|
121 |
S |
p. S48
|
artikel
|
| 75 |
NONCODING RNAs IN BURKITT LYMPHOMA
|
López, C.
|
|
|
121 |
S |
p. S2
|
artikel
|
| 76 |
NON-GERMINAL CENTER B-CELL SUBTYPE OF PEDIATRIC DISFFUSE LARGE B-CELL LYMPHOMA IN JAPAN: A MULTI-CASE ANALYSIS
|
Hori, D.
|
|
|
121 |
S |
p. S1
|
artikel
|
| 77 |
NON-HODGKIN LYMPHOMA PRESENTING WITH SPINAL CORD COMPRESSION: A POPULATION-BASED ANALYSIS ON THE NHL-BFM STUDY GROUP
|
Riquelme, A.
|
|
|
121 |
S |
p. S62
|
artikel
|
| 78 |
OBINUTUZUMAB (GA101) VS. RITUXIMAB SIGNIFICANTLY ENHANCES CELL DEATH, ANTIBODY-DEPENDENT CYTOTOXICITY AND IMPROVES OVERALL SURVIVAL AGAINST CD20+ PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBL) IN A XENOGRAFT NOD-SCID IL2RGNULL (NSG) MOUSE MODEL: A POTENTIAL TARGETED AGENT IN THE TREATMENT OF PMBL
|
Chu, Y.
|
|
|
121 |
S |
p. S14
|
artikel
|
| 79 |
OMITTING RADIATION IN YOUNG ADULT FEMALES WITH HODGKIN’S DISEASE, IS THERE AN IMPACT ON OUTCOME??
|
Semary, S.
|
|
|
121 |
S |
p. S59-S60
|
artikel
|
| 80 |
OPTIMIZING CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED NK CELL-MEDIATED CYTOTOXICITY COMBINED WITH ANTI-CD 20 OR ANTI-CD79 THERAPEUTIC ANTIBODIES AND NKTR-255 IN BURKITT LYMPHOMA (BL)
|
Chu, Y.
|
|
|
121 |
S |
p. S27
|
artikel
|
| 81 |
OUTCOME OF CHILDHOOD MATURE B-NHLs IN INDIA AND RELATION TO PROTOCOL USED-RESULTS OF A RETROSPECTIVE MULTI-CENTRE POOLED ANALYSIS
|
Moulik, N.
|
|
|
121 |
S |
p. S38-S39
|
artikel
|
| 82 |
OUTCOME OF CHILDREN TREATED FOR RECURRENT EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD)
|
Devine, K.
|
|
|
121 |
S |
p. S26
|
artikel
|
| 83 |
PDGFRβ DRIVES PROGRESSION BY ONCOGENE TRANSCRIPTION THROUGH STAT3/STAT5 HYPERACTIVATION IN ALCL
|
de los Fayos Alonso, I. Garces
|
|
|
121 |
S |
p. S69
|
artikel
|
| 84 |
PEDIATRIC AND YOUNG ADULT ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA GENETICALLY DIFFERS FROM THE ADULT COUNTERPART
|
Salmeron-Villalobos, J.
|
|
|
121 |
S |
p. S29
|
artikel
|
| 85 |
PEDIATRIC BIPHENOTYPIC NON-HODGKIN LYMPHOMA: A CASE REPORT AND REVIEW OF LITERATURE
|
Restivo, G.
|
|
|
121 |
S |
p. S70-S71
|
artikel
|
| 86 |
PEDIATRIC INFRADIAPHRAGMATIC HODGKIN’S LYMPHOMA: A UNIQUE IDENTITY
|
Eldeen, N. Ezz
|
|
|
121 |
S |
p. S61
|
artikel
|
| 87 |
PEDIATRIC LOW GRADE LYMPHOMAS: A REPORT FROM A SINGLE CENTRE
|
Kurucu, N.
|
|
|
121 |
S |
p. S20
|
artikel
|
| 88 |
PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE
|
Salmeron-Villalobos, J.
|
|
|
121 |
S |
p. S32
|
artikel
|
| 89 |
PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)
|
Vinti, L.
|
|
|
121 |
S |
p. S33-S34
|
artikel
|
| 90 |
PLASMA S-Evs miRNAs IN PEDIATRIC B-mALL: TUMOR BIOMARKERS AND TRANSFORMING FACTORS OF BONE MARROW NICHE
|
Damanti, C.
|
|
|
121 |
S |
p. S47
|
artikel
|
| 91 |
PLASMOBLASTIC LYMPHOMA (PBL) FOLLOWING LIVER TRANSPLANTATION. REPORT ON 2 PEDIATRIC PATIENTS
|
Dembowska-Baginska, B.
|
|
|
121 |
S |
p. S52-S53
|
artikel
|
| 92 |
POST-TRANSPLANT LYMPHOPROLIFERTIVE SYNDROME IN CHILDREN AND ADOLESCENTS UNDERGOING TRANSPLANTS HEPATIC AND RENAL: EPIDEMIOLOGICAL, DIAGNOSTIC AND THERAPY IN A BRAZILIAN
|
Luisi, F.
|
|
|
121 |
S |
p. S26-S27
|
artikel
|
| 93 |
PRELIMINARY RESULTS OF A PHASE 2 TRIAL OF OBINUTUZUMAB, IN COMBINATION WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (O-ICE) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED/ REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA
|
Hochberg, J.
|
|
|
121 |
S |
p. S62-S63
|
artikel
|
| 94 |
PRE-TRANSPLANT TREATMENT OF HEPATISPLENIC T-CELL LYMPHOMA (GAMMA-DELATA): A PEDIATRIC CASE REPORT
|
Abel, M.
|
|
|
121 |
S |
p. S53
|
artikel
|
| 95 |
PROGNOSTIC SIGNIFICANCE OF PD1, PD-L1 EXPRESSION, PATHOLOGICAL SUBTYPES AND METABOLIC ACTIVITY ON 18F-FDG PET/CT IN REFRACTORY/RELAPSING PEDIATRIC HODGKIN LYMPHOMA
|
Khedr, R.
|
|
|
121 |
S |
p. S61
|
artikel
|
| 96 |
PROGNOSTIC VALUE OF INTERIM 18FDG-PET-CT IN MATURE B-CELL NON-HODGKIN LYMPHOMA
|
Aydin, B.
|
|
|
121 |
S |
p. S42
|
artikel
|
| 97 |
REDUCING CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (CAYA) WITH MATURE LARGE B-CELL LYMPHOMA (RADICAL)
|
Audino, A.
|
|
|
121 |
S |
p. S40
|
artikel
|
| 98 |
REDUCING THE BURDEN OF ONCOLOGY CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGETED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMA (RADICAL, HODGKIN LYMPHOMA COHORT
|
Hochberg, J.
|
|
|
121 |
S |
p. S11-S12
|
artikel
|
| 99 |
REFINING THE GENETIC LANDSCAPE OF AGGRESSIVE B-CELL LYMPHOMA BY INTEGRATIVE MOLECULAR ANALYSIS
|
Mato, S.
|
|
|
121 |
S |
p. S49
|
artikel
|
| 100 |
REFRACTORY B-LYMPHOBLASTIC LYMPHOMA SUCCESSFULLY TREATED WITH TISAGENLECLEUCEL AND CONSOLIDATIVE STEM CELL TRANSPLANT
|
Dreyzin, A.
|
|
|
121 |
S |
p. S70
|
artikel
|
| 101 |
REPORT OF SYSTEMIC EBV-POSITIVE T-CELL LYMPHOMA OF CHILDHOOD ASSOCIATED WITH XMEN DISEASE CAUSED BY A NOVEL MUTATION
|
Man, J.
|
|
|
121 |
S |
p. S55
|
artikel
|
| 102 |
RESISTANCE TO ANAPLASTIC LYMPHOMA KINASE (ALK) TYROSINE KINASE INHIBITORS (TKIs) IN PAEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
|
Hare, L.
|
|
|
121 |
S |
p. S14-S16
|
artikel
|
| 103 |
RITUXIMAB CLEARANCE IN PEDIATRIC PATIENTS WITH MAATURE B-CELL NON-HODGKIN LYMPHOMA
|
Tölle, I.
|
|
|
121 |
S |
p. S23-S24
|
artikel
|
| 104 |
SAFETY AND TOLERABILITY OF MYELOABLATIVE CONDITIONING AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOLLOWED BY POLATUZUMAB VEDOTIN (PV) IMMNOCONJUGATE THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA
|
Gardenswartz, A.
|
|
|
121 |
S |
p. S24-S25
|
artikel
|
| 105 |
SAFETY PROFILE OF RITUXIMAB IN INITIAL TREATMENT OF CHILDREN AND ADOLESCENTS WITH MATURE B-NHL
|
Finger, J.
|
|
|
121 |
S |
p. S24
|
artikel
|
| 106 |
SEARCHING FOR THE CAUSES OF ANAPLASTIC LARGE CELL LYMPHOMA
|
James, E.
|
|
|
121 |
S |
p. S45
|
artikel
|
| 107 |
SHEDDING LIGHT ON GREY ZONE LYMPHOMA
|
Mason, N.
|
|
|
121 |
S |
p. S57
|
artikel
|
| 108 |
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF PEDIATRIC BURKITT LYMPHOMA REVEALS INTRA-TUMOR HETEROGENEITY
|
Corinaldesi, C.
|
|
|
121 |
S |
p. S22-S23
|
artikel
|
| 109 |
SOX11 AND EPSTEIN–BARR VIRUS MAY SUBSTITUTE EACH OTHER IN EARLY PATHOGENESIS OF BURKITT LYMPHOMA
|
Sureda-Gómez, M.
|
|
|
121 |
S |
p. S44
|
artikel
|
| 110 |
SUMMARY OF THE MID-TERM EFFICACY OF CHINA NET CHILDREN LYMPHOMA (CNCL)–MATURE B-CELL LYMPHOMA-2017 REGIMEN IN THE TREATMENT OF PEDIATRIC BURKITT’S LYMPHOMA
|
Meng, Z.
|
|
|
121 |
S |
p. S20
|
artikel
|
| 111 |
SURVIVAL OF PATIENTS WITH EXTRANODAL NK-CELL LYMPHOMA IN THE UNITED STATES
|
Xavier, A.
|
|
|
121 |
S |
p. S7
|
artikel
|
| 112 |
TARGETED THERAPY INCREASES PD-L1 PROTEIN EXPRESSION IN CELL LINES OF MEDIASTINAL LYMPHOMA
|
Hutchison, R.
|
|
|
121 |
S |
p. S43-S44
|
artikel
|
| 113 |
THE CHALLENGE OF PROSPECTIVE DISTINCTION BETWEEN NON-NEOPLASTIC VERUS NEOPLASTIC EBV-ASSOCIATED HLH
|
Gulati, N.
|
|
|
121 |
S |
p. S6-S7
|
artikel
|
| 114 |
THE MITOCHONDRIAL CHAPERONE TRAP1: A BRIDEGE BETWEEN METABOLIC REWIRING AND EPIGENETIC REMODELING IN DLBCL
|
Ferrone, L.
|
|
|
121 |
S |
p. S45-S46
|
artikel
|
| 115 |
THE PROFILING OF CIRCULATING TUMOR DNA IN PEDIATRIC MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL): A MULTICENTER, PROSPECTIVE CLINICAL STUDY
|
Wang, J.
|
|
|
121 |
S |
p. S30-S32
|
artikel
|
| 116 |
THE PROGNOSTIC VALUE OF BULK DISEASE IN TREATMENT OUTCOMES OF PEDIATRIC HODGKIN LYMPHOMA TREATED ACCORDING TO EURONET PROTOCOL
|
Eldeen, N. Ezz
|
|
|
121 |
S |
p. S60-S61
|
artikel
|
| 117 |
Title Page
|
|
|
|
121 |
S |
p. i
|
artikel
|
| 118 |
TOXICITY OF TARGETED THERAPY WITH IMATINIB IN PATIENT WITH NIJMEGEN BREAKAGE SYNDROME AND T -LYMPHOBLASTIC LYMPHOMA/LEUKEMIA HARBORING ZBTB16-ABL1 FUSION
|
Krenova, Z.
|
|
|
121 |
S |
p. S69-S70
|
artikel
|
| 119 |
TP53 STATUS RISK STRATIFIES PATIENTS WITH CLINICALLY DEFINED HIGH-RISK DISEASE PAEDIATRIC B-CELL NON-HODGKIN LYMPHOMA
|
Newman, Alexander M.
|
|
|
121 |
S |
p. S51-S52
|
artikel
|
| 120 |
TRANSCRIPTION AND REPLICATION IMPAIRMENTS DRIVING MYC-INDUCED B AND T CELL LYMPHOBLASTIC LYMPHOMAS
|
Sinha, A.
|
|
|
121 |
S |
p. S37
|
artikel
|
| 121 |
TREATING LYMPHOMA IN THE PANDEMIC ERA: WHAT WE LEARNED FROM OUR EXPERIENCE AT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
|
Gattuso, G.
|
|
|
121 |
S |
p. S55-S56
|
artikel
|
| 122 |
UNUSUAL LYMPHOMA WITH CLINICAL AND PATHOLOGICAL FEATURES OF SUBCUTANEOUS PANNICULITIS-LIKE PERIPHERIAL T CELL LYMPHOMA (SPTCL) BUT WITH GAMMA/DELTA IMMUNOPHENOTYPE AND BIALLELIC HAVCR2 GERMLINE MUTATIONS
|
Molloy, F.
|
|
|
121 |
S |
p. S53
|
artikel
|
| 123 |
UPFRONT PEMBROLIZUMAB IN THERAPY OF NIJMEGEN BREAKAGE SY (NBS) PATIENT WITH HODGKIN LYMPHOMA DEMONSTRATED HIGH EFFICACY AND WAS WELL TOLERATED
|
Krenova, Z.
|
|
|
121 |
S |
p. S59
|
artikel
|
| 124 |
VARIANT ALK-FUSION POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): A POPULATION-BASED COHORT OF THE NHL-BFM STUDY GROUP
|
Damm-Welk, C.
|
|
|
121 |
S |
p. S28
|
artikel
|
| 125 |
VARYING OUTCOMES OF MATURE T AND NK LYMPHOMA IN PEDIATRIC AND ADOLESCENT/YOUNG ADULT PATIENTS: A SINGLE INSTITUTION EXPERIENCE
|
Lin, C.
|
|
|
121 |
S |
p. S54
|
artikel
|
| 126 |
WHOLE GENOME SEQUENCING REVEALS MOLECULAR HETEROGENEITY OF DIFFUSE B-CELL LYMPHOMAS IN CHILDREN WITH NIJMEGEN BREAKAGE SYNDROME
|
Pastorczak, A.
|
|
|
121 |
S |
p. S50
|
artikel
|
Tijdschrift beschrijving